Lisa Park

Biosketch / Results /

Lisa Park, M.D.

Clinical Associate Professor; Associate Dir Residency Training
Department of Ophthalmology (Resident Train )

Clinical Addresses

530 FIRST AVENUE, HCC 3B
10016, NY NEW YORK
Hours: Wed. 9 - 4
Handicap Access: yes
Phone: 212-263-2573
Fax: 212-263-2574

« Back to Results

Medical Specialties

Ophthalmology

Medical Expertise

Glaucoma, General Ophthalmology, Laser Surgery, Corneal Disease, Laser Vision Correction- Lasik, External Disease Of The Eye, Cataracts & Minimally Invasive Cataract Surgery, Refractive Surgery

Clinical Responsibilities

Dr. Park is a graduate of Harvard College and the Yale School of Medicine. She completed her ophthalmology residency at the Manhattan Eye, Ear & Throat Hospital and the NYU School of Medicine. She then went on to complete a subspecialty fellowship in anterior segment and refractive surgery at MEETH. Dr. Park has numerous research papers and publications to her credit. Dr. Park is currently the Associate Residency Program Director at NYU and the Chief of Service at Bellevue Hospital Center.

Associate Director of Residency Program, Department of Ophthalmology, NYU School of Medicine

Languages

Spanish

Insurance

AETNA HMO, AETNA MEDICARE, AETNA POS, AETNA PPO, BeechSt, Cigna HMO/POS, Cigna PPO, EBCBS CHLD HLTH, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GHI CBP, GREATWEST PPO, HEALTHPLUS CHLD HLTH, HEALTHPLUS FAM HLTH, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, HealthPlus Medicaid, LOCAL 1199 PPO, MAGNACARE PPO, METROPLUS CHLD HLTH, METROPLUS FAM HLTH, MULTIPLAN/PHCS PPO, MetroPlus Medicaid, NYS EMPIRE PLAN, OXFORD FREEDOM, Oxford Liberty, PHCS, UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIER, UPN Elite

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2009 — Ophthalmology

Education

1997 — Yale University School of Medicine, Medical Education
1997-1998 — St. Barnabas Medical Center (Transitional), Internship
1998-1999 — Manhattan Eye, Ear & Throat Hospital (Ophthalmology), Residency Training
2001-2003 — NYU Medical Center (Ophthalmology), Residency Training
2003-2004 — Manhattan Eye, Ear & Throat Hospital (Refractive Surgery), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search#about

The use of micro-probes in laser photolysis cataract extraction
Park, L; Manzitti, I; Dodick, JM
2005 ;46(Suppl):?-? abstract #750, Investigative ophthalmology & visual science. IOVS
— id: 59365, year: 2005, vol: 46, page: ?, stat: Journal Article,

Laser photolysis cataract extraction using the Wehener spoon
Park, L; Ali, I; Dodick, J
2004 APR abstract #276;45(Suppl)):U157-U157, Investigative ophthalmology & visual science. IOVS
— id: 59366, year: 2004, vol: 45, page: U157, stat: Journal Article,

Laser photolysis cataract extraction, irrigation fluid and corneal edema
Park, L; Miller, AI; Ali, I; Dodick, J
2003 MAY abstract #228;44(3):U40-U40, Investigative ophthalmology & visual science. IOVS
— id: 55415, year: 2003, vol: 44, page: U40, stat: Journal Article,

The effect of terrorism on ophthalmology services in New York City
Park, L
2002 MAY abstract #344;43(3):U68-U68, Investigative ophthalmology & visual science. IOVS
— id: 55477, year: 2002, vol: 43, page: U68, stat: Journal Article,

Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
1999 Sep;19(3):219-227, Current eye research
PURPOSE. To measure vitreous levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cellular adhesion molecule-1 (sVCAM-1) in the eyes of patients with retinal detachment (RD) due to proliferative diabetic retinopathy (PDR) or proliferative vitreoretinopathy (PVR) and to determine whether the levels of these mediators correlated with clinical parameters of disease. METHODS. Undiluted vitreous specimens were collected from 50 eyes of 48 patients undergoing vitrectomy for traction RD due to PDR (21 specimens) and recurrent RD due to PVR (19 specimens). Control vitreous specimens were obtained from patients undergoing macular hole repair (10 specimens). The levels of sICAM-1 and sVCAM-1 were measured in each sample by specific enzyme-linked immunoadsorbent assays. RESULTS. Vitreous levels of sICAM-1 were significantly increased in vitreous specimens from both PVR (median +/- SD; 12.0 +/- 76.3 ng/ml; P < 0.01) and PDR (8.4 +/- 24.0 ng/ml; P < 0.01) when compared to vitreous from eyes with macular holes (0. 3 +/- 4.2 ng/ml). Vitreous levels of sVCAM-1 were significantly increased in both PVR (36.5 +/- 255.2 ng/ml; P < 0.001) and PDR (26. 2 +/- 93.5 ng/ml; P < 0.01) when compared to control vitreous (17.7 +/- 7.8 ng/ml). The vitreous levels of sICAM-1 were higher in cases of PDR which developed recurrent proliferative disease (P < 0.01) and recurrent RD (P = 0.01), whereas the levels of sICAM-1 in PVR and sVCAM-1 in PDR and PVR did not significantly correlate with these clinical parameters. CONCLUSIONS. Soluble forms of ICAM-1 and VCAM-1 are increased in the vitreous cavity of patients with RD due to PDR or PVR, reflecting the inflammatory nature of these conditions and suggesting a possible role for these mediators in the pathogenesis of proliferative retinal disease. The vitreous levels of these sCAMs at the time of surgery may serve as a marker of inflammation, but their specific levels do not predict the likelihood of recurrent proliferation or surgical anatomic success in most cases of PVR and PDR
— id: 59362, year: 1999, vol: 19, page: 219, stat: Journal Article,

Effect of a non-emergent referral program on ocular complaints presenting to an inner city emergency department
Blaho, KE; Winbery, SL; Park, LJ
1999 MAR 15 abstract #1501B409;40(4):S284-S284, Investigative ophthalmology & visual science. IOVS
— id: 59368, year: 1999, vol: 40, page: S284, stat: Journal Article,

The use and efficacy of disinfection methods during applanation tonometry
Leung, M; Park, L; Schrier, A
1999 MAR 15 abstract #148B108;40(4):S28-S28, Investigative ophthalmology & visual science. IOVS
— id: 59367, year: 1999, vol: 40, page: S28, stat: Journal Article,

Macular epiretinal membrane associated with subfoveal retinal pigment epitheliopathy (SRPE)
Park, L; Wald, KJ
1999 MAR 15 abstract #4969B772;40(4):S942-S942, Investigative ophthalmology & visual science. IOVS
— id: 59369, year: 1999, vol: 40, page: S942, stat: Journal Article,

Experimental preretinal neovascularization by laser-induced venous thrombosis in rats
Saito Y; Park L; Skolik SA; Alfaro DV; Chaudhry NA; Barnstable CJ; Liggett PE
1997 Jan;16(1):26-33, Current eye research
PURPOSE: Retinal ischemia and neovascularization (NV) are important components of many retinal disorders. To facilitate further investigation of retinal ischemia and neovascularization, we sought to develop a reproducible in vivo experimental model of venous occlusion by photodynamic thrombosis in rats. METHODS: After anesthesia, 27 eyes of pigmented rats received an intraperitoneal injection of 0.2 ml of, 10% sodium fluorescein 15 minutes prior to laser treatment. With a blue-green argon laser, selected venous sites next to the optic nerve head were photocoagulated indirectly with a 78 diopter lens. Venous occlusion was accomplished using laser parameters of 1.0 second, 50 microns, and 50-100 mW. For a control group, 10 eyes were coagulated on the retina between major vessels using the same parameters after fluorescein injection. For a second control group, 1% sodium hyaluronate was injected into the subretinal space to make a long-standing retinal detachment in 5 eyes. RESULTS: With 1-8 laser impulses, each venous occlusion was obtained and was associated with extreme venous constriction and tortuousity. Retinal edema became evident 10-30 minutes after treatment in the sectors associated with the occluded veins. This edema became a bullous retinal detachment (RD) within 12 hours and intra-retinal hemorrhage was observed. The retinal edema continued for 3-10 days and the retinas reattached spontaneously. Prior to or after retinal reattachment 70% (19/27) of eyes developed retinal NV and tractional RD. Of these, 11 developed NV of the optic disc (NVD), 6 developed NV elsewhere (NVE), and 2 developed NVD and NVE. In 30% (8/27) of the eyes, retinal edema resolved without evidence of NV. In control groups no eyes showed either circulatory disorders or evidence of NV. CONCLUSIONS: This is a new model of retinal ischemia and associated neovascularization established by venous thrombosis that is easily reproducible. Many aspects of rat retinal physiology are known and this model has promise as an avenue for further investigation
— id: 59363, year: 1997, vol: 16, page: 26, stat: Journal Article,

Experimental-model Of Preretinal Neovascularization By Laser Photodynamic Venous Thrombosis In Rats
Saito, Y; Park, L; Skolik, SA; Alfaro, DV; Chaudhry, NA; Barnstable, CJ; Liggett, PE
1994 MAR 15 ;35(4):1374-1374, Investigative ophthalmology & visual science. IOVS
— id: 59370, year: 1994, vol: 35, page: 1374, stat: Journal Article,